ALB and cancer: Combining the advantage of mannose and albumin, a dual-targeting mannosylated albumin nanoparticle was constructed; this nanoparticle targeting SPARC and MR (mannose receptor) can effectively target both cancer cells and M2 macrophages, leading to the reprogramming of the tumor microenvironment [229].